Tech Company Financing Transactions

Personal Genome Diagnostics Funding Round

On 1/5/2018, Personal Genome Diagnostics secured $75 million in Series B funding from Bristol-Myers Squibb, New Enterprise Associates and Co-win Healthcare Fund.

Transaction Overview

Company Name
Personal Genome Diagnostics
Announced On
1/5/2018
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series B
Investors

Bristol-Myers Squibb (Lead Investor) (Paul Biondi)

New Enterprise Associates (Lead Investor) (Justin Klein)

Co-win Healthcare Fund

Helsinn Investment Fund

Inova Strategic Investments

Maryland Venture Fund

Windham Venture Partners (Felix Dawson)

Proceeds Purpose
The new funding will be used to support PGDx's strategic initiative to bring regulated in vitro diagnostic (IVD) genome testing to cancer patients and their physicians worldwide to help tailor treatments according to the specific characteristics of each patient's cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2809 Boston St. 503
Baltimore, MD 21224
USA
Phone
(443) 602-8833
Website
www.personalgenome.com
Email Address
[email protected]
Overview
Understanding the genetic sequence of individual patients is becoming an important feature of medical care. This is particularly true in cancer, where the accumulation of genetic alterations in the tumor represents a universal feature of the disease.
Profile
Personal Genome Diagnostics LinkedIn Company Profile
Social Media
Personal Genome Diagnostics Company Twitter Account
Company News
Personal Genome Diagnostics News
Facebook
Personal Genome Diagnostics on Facebook
YouTube
Personal Genome Diagnostics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Megan Bailey
  Megan Bailey LinkedIn Profile  Megan Bailey Twitter Account  Megan Bailey News  Megan Bailey on Facebook
Chief Financial Officer
Jack Crowley
  Jack Crowley LinkedIn Profile  Jack Crowley Twitter Account  Jack Crowley News  Jack Crowley on Facebook
Chief Information Officer
Samuel Angiuoli
  Samuel Angiuoli LinkedIn Profile  Samuel Angiuoli Twitter Account  Samuel Angiuoli News  Samuel Angiuoli on Facebook
VP - Bus. Development
Chris Hauck
  Chris Hauck LinkedIn Profile  Chris Hauck Twitter Account  Chris Hauck News  Chris Hauck on Facebook
VP - Operations
Scott Gotshall
  Scott Gotshall LinkedIn Profile  Scott Gotshall Twitter Account  Scott Gotshall News  Scott Gotshall on Facebook
VP - R & D
Abigail Mcelhinny
  Abigail Mcelhinny LinkedIn Profile  Abigail Mcelhinny Twitter Account  Abigail Mcelhinny News  Abigail Mcelhinny on Facebook
VP - Regulatory Affairs
Jennifer Dickey
  Jennifer Dickey LinkedIn Profile  Jennifer Dickey Twitter Account  Jennifer Dickey News  Jennifer Dickey on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/5/2018: MoneyLion venture capital transaction
Next: 1/5/2018: Net Element venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.